← Leaderboards
Roberta Faccio
Washington University
$8,150,057
Attributed
$8,150,057
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $770.8K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,150,057 · 4
By mechanism
R01$8,150,057 · 4
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- John F Dipersio$33,235,840
- Emily M Eul$146,206
- Susan Priscilla Canny$439,829
- Sun Joo Lee$157,500
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBoneImmuneInflammatoryProductionCytokineIn VivoBaseIn VitroAffectSignaling MoleculeOsteolyticMediatingBone LossOsteoclastsTumorPhenotypeBone MarrowNovel Therapeutic InterventionResponseLeadT-Cell ActivationT-LymphocyteArthritis
Grant awards (23)
Role of Osterix+ Osteolineage Cells in Primary and Metastatic Breast Cancer$413,711
R01 · FY2025 · CA · contact PI
Role of Osterix+ Osteolineage Cells in Primary and Metastatic Breast Cancer$393,846
R01 · FY2024 · CA · contact PI
Role of Bone in Primary and Metastatic Cancer$342,268
R01 · FY2024 · CA · contact PI
Role of Osterix+ Osteolineage Cells in Primary and Metastatic Breast Cancer$409,948
R01 · FY2023 · CA · contact PI
Role of Bone in Primary and Metastatic Cancer$353,076
R01 · FY2023 · CA · contact PI
Role of Bone in Primary and Metastatic Cancer$353,076
R01 · FY2022 · CA · contact PI
Role of Bone in Primary and Metastatic Cancer$360,281
R01 · FY2021 · CA · contact PI
Novel Regulators of Inflammatory Arthritis and Bone Erosion$385,049
R01 · FY2020 · AR · contact PI
Role of Bone in Primary and Metastatic Cancer$360,281
R01 · FY2020 · CA · contact PI
Novel Regulators of Inflammatory Arthritis and Bone Erosion$385,618
R01 · FY2019 · AR · contact PI
Novel Regulators of Inflammatory Arthritis and Bone Erosion$392,753
R01 · FY2018 · AR · contact PI
Novel Regulators of Inflammatory Arthritis and Bone Erosion$399,376
R01 · FY2016 · AR · contact PI
Novel Regulators of Inflammatory Arthritis and Bone Erosion$420,461
R01 · FY2015 · AR · contact PI
Regulatory Pathways in Osteoclasts and Immune Cells during Inflammatory Arthritis$350,379
R01 · FY2015 · AR · contact PI
Regulatory Pathways in Osteoclasts and Immune Cells during Inflammatory Arthritis$352,781
R01 · FY2014 · AR · contact PI
Regulatory Pathways in Osteoclasts and Immune Cells during Inflammatory Arthritis$352,085
R01 · FY2013 · AR · contact PI
Regulatory Pathways in Osteoclasts and Immune Cells during Inflammatory Arthritis$381,698
R01 · FY2011 · AR · contact PI
Regulatory Pathways in Osteoclasts and Immune Cells during Inflammatory Arthritis$402,177
R01 · FY2010 · AR · contact PI
Regulatory Pathways in Osteoclast Formation and Function$286,388
R01 · FY2009 · AR · contact PI
REGULATORY PATHWAYS IN OSTEOCLAST FORMATION AND FUNCTION$174,400
R01 · FY2009 · AR · contact PI
Regulatory Pathways in Osteoclast Formation and Function$286,388
R01 · FY2008 · AR · contact PI
REGULATORY PATHWAYS IN OSTEOCLAST FORMATION AND FUNCTION$292,232
R01 · FY2007 · AR · contact PI
REGULATORY PATHWAYS IN OSTEOCLAST FORMATION AND FUNCTION$301,785
R01 · FY2006 · AR · contact PI